Moderna aims to price coronavirus vaccine at $50-$60 per course: FT

·

·

Moderna aims to price coronavirus vaccine at $50-$60 per course: FT

(Reuters) – Moderna Inc is planning to price its coronavirus vaccine at $50 to $60 per course, at least $11 more than another vaccine from Pfizer Inc and BioNTech, the Financial Times reported on Tuesday, citing unnamed sources. FILE PHOTO: A sign marks …
See Original Article

Amgen second-quarter revenue rises 6%, shares fall 2%

(Reuters) – Amgen Inc on Tuesday reported second-quarter revenue rose 6% as higher sales of newer drugs, including recently-added psoriasis treatment Otezla, offset declining sales of older medicines. FILE PHOTO: An Amgen sign is seen at the company’s …
See Original Article

Visa tops earnings expectations but travel category remains slow to snap back

Amount of money spent by Visa customers drops 10%, and company sees only marginal improvement in transactions done between shoppers and merchants from different countries. Krisztian Bocsi/Bloomberg. Email icon; Facebook icon; Twitter icon …
See Original Article

Litigation funder Validity touts $100m infusion, in-house hire as pandemic fuels demand

Third-party litigation funder Validity Finance on Tuesday announced it had raised an additional $100 million and said it had brought on a former transactions lawyer from Fried, Frank, Harris, Shriver & Jacobson as its first in-house counsel. The $100 million …
See Original Article

Blackbaud Recognized by Forbes as One of America's Best Employers for Women

CHARLESTON, S.C., July 28, 2020 /PRNewswire/ — Blackbaud (NASDAQ: BLKB), the world’s leading cloud software company powering social good, announces today that it has been named to Forbes’ Best Employers for Women 2020 list. Blackbaud, which …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.